|
|
|
Preliminary
Course Program (revised)
MasterClass Program
|
Faculty |
| A/Prof Ken Bradstock |
Head of BMT Service, Westmead Hospital Sydney |
| Dr Sharon Chen |
CIDM, Westmead Hospital, Sydney |
| A/Prof David Ellis |
Mycology Unit, Women’s & Children’s Hospital, Adelaide |
|
Dr
Nicky Gilroy |
CIDM, Westmead Hospital, Sydney |
|
A/Prof David Gottlieb |
Faculty of Medicine, Westmead Hospital, Sydney |
|
Dr
Tom Gottlieb |
Infectious Diseases & Microbiology, Concord Hospital,
Sydney |
|
Dr
Catriona Halliday |
CIDM, Westmead Hospital, Sydney |
|
Dr
Peter Hopkins |
Queensland Heart-Lung Transplant Unit, Prince
Charles Hospital, Brisbane |
|
A/Prof Debbie Marriott |
Dept of Microbiology, St Vincent’s Hospital, Sydney |
|
A/Prof Wieland Meyer |
CIDM, Westmead Hospital, Sydney |
|
Dr
Geoffrey Playford |
Infection Management Services, Princess Alexandra
Hospital, Brisbane |
|
Dr
Sam Rudham |
Staff Specialist Intensive Care, St Vincent's Hospital,
Sydney |
|
Dr
Monica Slavin |
Victorian Infectious Disease Service, Royal Melbourne
Hospital, Melbourne |
|
Prof Tania Sorrell |
CIDM, Westmead Hospital, Sydney |
|
Prof Jeff Szer |
Dept Clinical Haematology & Bone Marrow Transplant
Service, Royal Melbourne Hospital, Melbourne |
|
Dr
Karin Thursky |
Victorian Infectious Disease Service, Royal Melbourne
Hospital, Melbourne |
|
A/Prof David Tuxen |
Dept Intensive Care & Hyperbaric Medicine, Alfred
Hospital, Melbourne |
|
Preliminary MasterClass
Program (revised 15/10/07) |
|
Thursday 1 November 2007
|
|
anytime
between
12.00pm -
4.00pm |
MasterClass Registration & Hotel Check-In
(front
lawns, Reef View Hotel) |
|
6.00pm -
8.00pm |
Welcome Mixer -
supper & cocktails
(incl with registration) |
| |
|
Friday 2 November 2007
| Endeavour Room (next to Toucan Tangos) |
|
8.30am - 10.00am
|
Activity in BMT & what the future will hold
Jeff
Szer |
|
Update on chemotherapy, conditioning regimens &
monoclonal antibodies
Ken
Bradstock |
|
10.00am -
10.30am |
Morning
Tea Break |
|
10.30am - 11.15am |
Invasive fungal infections in the solid organ transplant
patient
Peter
Hopkins |
|
11.15am - 11.45pm |
The
Aspergillus (ASPID) study
Sharon Chen |
|
11.45am - 12.15pm |
Antifungal susceptibility testing and resistance trends
David
Ellis |
|
12.15pm -
1.15pm |
Lunch
Break |
|
1.15pm - 2.00pm |
Invasive fungal infections in the Surgical & ICU patient
David
Tuxen |
|
2.00pm - 2.30pm |
Fungal Sinusitis
Sharon Chen |
|
2.30pm -
3.00pm |
Afternoon
Tea Break |
|
3.00pm - 4.00pm |
T
cell responses to Aspergillus & an update on
adoptive T cell immunotherapy for invasive
Aspergillus infections in HSCT patients
David
Gottlieb |
|
5.15pm -
9.00pm |
BBQ
Safari Tour (incl with registration) |
| |
|
Saturday 3 November 2007
| Endeavour Room (next to Toucan Tangos)
|
|
8.30am - 9.00am |
Molecular epidemiology in clinical mycology
Wieland Meyer |
|
9.00am - 9.30am |
Antifungal prophylaxis strategies in the ICU
Geoffrey Playford |
|
9.30am - 10.00am |
When to use combination therapy?
Tania
Sorrell |
|
10.00am -
10.30am |
Morning
Tea Break |
|
10.30am - 11.00am |
Primary & secondary antifungal prophylaxis in
haematology malignancies
Monica Slavin |
|
11.00am - 11.30am |
Treatment update (antifungal guidelines)
Kas
Thursky |
|
11.30am - 12.00pm |
Infection control & immunocompromised hosts
Nicky
Gilroy |
|
12.00pm -
1.00pm |
Lunch
Break |
|
1.00pm - 1.30pm |
Zygomycosis – are there new management options?
Tom
Gottlieb |
|
1.30pm - 2.00pm |
Scedosporium & Fusarium
infections in Australia
Monica Slavin |
|
2.00pm - 2.30pm |
Candida
infections – difficult sites
Sam
Rudham |
|
2.30pm -
3.00pm |
Afternoon
Tea Break |
|
3.00pm - 3.30pm |
Clinical value of serology & molecular tests in
diagnosing invasive aspergillosis in high risk patients
Catriona Halliday |
|
3.30pm - 4.00pm |
Antifungal serum
levels
Debbie Marriott |
|
7.30pm |
Conference Dinner (incl with registration) |
|
workshop |
|
Sunday 4 November 2007
| Endeavour Room (next to Toucan Tangos)
|
|
OPTIONAL SATELLITE WORKSHOP | for
laboratory staff (workshop fee applies) |
|
9.00am - 11.30am |
Descriptions of
medical fungi and
in vitro antifungal susceptibility testing
David
Ellis |
|
|
